Changing the Trajectory of Gastrointestinal Cancers

Revolutionary science offers the greatest promise for those facing gastrointestinal cancers today. Listen to a conversation with Brian Wolpin, MD, MPH, Chief of the Division of Gastrointestinal Oncology and the Robert T. and Judith B. Hale Chair in Pancreatic Cancer at Dana-Farber, to hear how his team is working to change the course of these cancers by investing in translational and clinical research programs that are pushing boundaries. Dr. Wolpin is joined by Kimmie Ng, MD, MPH, and James Cleary, MD, PhD, for an interactive dialogue on the Center for Gastrointestinal Oncology’s progress and collaborative approach to overcome challenges in gastrointestinal cancers.

To learn more, visit the Revolutionary Science section of this site.

Give Now

Thank you for your interest in learning more about The Dana-Farber Campaign. You have been added to our email list and will receive updates on ways to join us in defying cancer. You can unsubscribe at any time.

There has been an issue submitting your request. Please try again.

Founded in Boston in 1947, Dana-Farber is a principal teaching affiliate of Harvard Medical School and a federally designated Comprehensive Cancer Center that develops and disseminates innovative patient therapies and scientific discoveries throughout the world. About Our Patient Stories: Dana-Farber shares patient stories which may include descriptions of actual medical results. Dana-Farber provides personalized care for each patient based on their unique needs; their experiences and results will vary.

At Dana-Farber we are committed to an inclusive community where human differences are valued and celebrated, and where all are welcome. We work every day to create an innovative, caring, and inclusive environment where each patient, family, and staff member feels valued and respected.